OIM
NXTM

Oracle Investment Management’s NxStage Medical Inc. NXTM Stock Holding History

Oracle Investment Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-142,800
Closed -$4K – 25
2017
Q4 		$4K Sell
142,800
-1,926,000
-93% -$50.7M ﹤0.01% 24
2017
Q3 		$310K Buy
2,068,800
+1,608,000
+349% +$42.9M 0.05% 20
2017
Q2 		$1.47M Buy
460,800
+360,800
+361% +$8.93M 0.23% 17
2017
Q1 		$20K Buy
+100,000
New +$2.76M ﹤0.01% 21

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Oracle Investment Management's NXTM Position: Q3 2017 in Review

Oracle Investment Management sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 2,276,106 shares — an estimated $60.7M sold.

Oracle Investment Management first reported a position in NXTM in Q2 2013 and held it in 17 quarters. The position peaked at $73M in Q1 2017. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

  • Oracle Investment Management reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
  • Oracle Investment Management sold 2,276,106 NxStage Medical Inc. shares in Q3 2017, an estimated $60.7M.
  • Oracle Investment Management first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 17 quarters.
  • Oracle Investment Management's NxStage Medical Inc. position peaked at $73M in Q1 2017.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Oracle Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.